Submission for OMB Review; 30-Day Comment Request; Inclusion Enrollment Report Form Conversion to Common Form, Office of the Director (OD), 43558-43559 [2021-17037]
Download as PDF
<![CDATA[
43558
Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices
Emphasis Panel; NIAID 2021 DMID Omnibus
BAA (HHS–NIH–NIAID–BAA2021–01)
Research Area 002: Development of
Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and
Emerging Infectious Diseases-Bacterial
Therapeutics.
Date: September 1–3, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Patricia A. Gonzales
Hurtado, Ph.D., Scientific Review Officer,
Scientific Review Program, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3E71A, Rockville, MD 20852, 240–627–3556,
Patricia.Gonzales@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 4, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16903 Filed 8–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Mentored Clinical Scientist
Research Career Development Award (Parent
K08 Independent Clinical Trial Not
Allowed).
Date: August 31, 2021.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
VerDate Sep<11>2014
17:26 Aug 06, 2021
Jkt 253001
Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mario Cerritelli, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F58, Rockville, MD
20852, 240–669–5199, cerritem@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 4, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16904 Filed 8–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: August 31, 2021.
Open: 9:30 a.m. to 1:45 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda, MD 20892–4872, https://
videocast.nih.gov (Virtual Meeting).
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast https://videocast.nih.gov Please
note, the link to the videocast meeting will
be posted within a week of the meeting date.
Any member of the public may submit
written comments no later than 15 days after
the meeting.
Closed: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda, MD 20892–4872 (Virtual Meeting).
Contact Person: Melinda Nelson, Director,
Office of Extramural Operations, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, Grants Management Branch,
45 Center Drive, Natcher Building, Room
5A49, Bethesda, MD 20892, (301) 594–3535,
mn23z@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: July 28, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16942 Filed 8–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Inclusion
Enrollment Report Form Conversion to
Common Form, Office of the Director
(OD)
National Institutes of Health,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
ADDRESSES:
E:\FR\FM\09AUN1.SGM
09AUN1
43559
Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Tawanda
Abdelmouti, Program Analyst, Office of
Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 805–C, Bethesda, Maryland 20892,
or call a non-toll-free number 301–435–
0978 or Email your request, including
your address to
ProjectClearanceBranch@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 22, 2021, page 21324
(86 FR 21234) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. Office of the
Director, Office of Extramural Research
(OER), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Inclusion
Enrollment Form Conversion to
Common Form—NEW, 0925–XXXX,
Expiration Date XX/XX/XXXX, Office of
the Director (OD), National Institutes of
Health (NIH).
Need and Use of Information
Collection: NIH’s Office of Extramural
Research (OER) Office of Policy and
Extramural Research Administration
(OPERA) is converting the Inclusion
Enrollment Report form to allow its use
by the Department of Defense (DoD).
The Inclusion Enrollment Report is used
for all applications involving NIHdefined clinical research. This form is
used to report both planned and
cumulative (or actual) enrollment, and
describes the sex/gender, race, and
ethnicity of the study participants.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
194,574.
ESTIMATED ANNUALIZED BURDEN HOURS
Information
collection forms
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
Inclusion enrollment form ................................................................................
64,858
1
3
194,574
Total ..........................................................................................................
........................
64,858
........................
194,574
Dated: July 30, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–17037 Filed 8–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:26 Aug 06, 2021
Jkt 253001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; AD Risk
Factors.
Date: September 8, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–496–9667, nijaguna.prasad@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 4, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16950 Filed 8–6–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; PHS Applications
and Pre-Award Related Reporting
(Office of the Director)
National Institutes of Health,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
ADDRESSES:
E:\FR\FM\09AUN1.SGM
09AUN1
]]>Agencies
[Federal Register Volume 86, Number 150 (Monday, August 9, 2021)]
[Notices]
[Pages 43558-43559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17037]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Inclusion
Enrollment Report Form Conversion to Common Form, Office of the
Director (OD)
AGENCY: National Institutes of Health, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent
[[Page 43559]]
within 30 days of publication of this notice to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting
``Currently under 30-day Review--Open for Public Comments'' or by using
the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Tawanda Abdelmouti, Program Analyst, Office of
Policy for Extramural Research Administration, 6705 Rockledge Drive,
Suite 805-C, Bethesda, Maryland 20892, or call a non-toll-free number
301-435-0978 or Email your request, including your address to
[email protected]. Formal requests for additional
plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on April 22, 2021, page
21324 (86 FR 21234) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. Office of the Director, Office
of Extramural Research (OER), National Institutes of Health, may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a currently
valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Inclusion Enrollment Form Conversion to Common
Form--NEW, 0925-XXXX, Expiration Date XX/XX/XXXX, Office of the
Director (OD), National Institutes of Health (NIH).
Need and Use of Information Collection: NIH's Office of Extramural
Research (OER) Office of Policy and Extramural Research Administration
(OPERA) is converting the Inclusion Enrollment Report form to allow its
use by the Department of Defense (DoD). The Inclusion Enrollment Report
is used for all applications involving NIH-defined clinical research.
This form is used to report both planned and cumulative (or actual)
enrollment, and describes the sex/gender, race, and ethnicity of the
study participants.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 194,574.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total annual
Information collection forms respondents responses per response (in burden hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Inclusion enrollment form....................... 64,858 1 3 194,574
---------------------------------------------------------------
Total....................................... .............. 64,858 .............. 194,574
----------------------------------------------------------------------------------------------------------------
Dated: July 30, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-17037 Filed 8-6-21; 8:45 am]
BILLING CODE 4140-01-P
